(Q35207762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Rahul Deshpande

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Derek O'Reilly

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

12 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hepatology

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

686074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

14 February 2020

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Pretreatment assessment of hepatocellular carcinoma: expert consensus statement

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Current strategy for staging and treatment: the BCLC update and future prospects.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

NCCN clinical practice guidelines in oncology: hepatobiliary cancers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Staging systems in hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Management of hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Portal vein embolization before right hepatectomy: prospective clinical trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Complications of radiofrequency coagulation of liver tumours

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Hepatic resection versus transplantation for hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170839

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

28 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Total tumor volume predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Surgical treatment of hepatocellular carcinoma: expert consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: Long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F686074

Living-donor liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study

1 reference

12 December 2020

Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases

1 reference

12 December 2020

Hepatectomy for hepatocellular carcinoma patients who meet the Milan criteria

1 reference

12 December 2020

Liver organ allocation for hepatocellular carcinoma: are we sure?

1 reference

12 December 2020

Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Preoperative portal vein embolization for major liver resection: a meta-analysis

1 reference

12 December 2020

Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis

1 reference

12 December 2020

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

1 reference

12 December 2020

Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria

1 reference

12 December 2020

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

1 reference

12 December 2020

Predictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma

1 reference

12 December 2020

Personal experience with 411 hepatic resections

1 reference

12 December 2020

Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival

1 reference

12 December 2020

American Society of Transplant Surgeons' position paper on adult-to-adult living donor liver transplantation

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/686074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994867%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

21994867

1 reference